[Form 4] AGILENT TECHNOLOGIES, INC. Insider Trading Activity

Rhea-AI Filing Summary

Agilent Technologies (A) reported an equity award to a senior executive. A Senior Vice President received 6,922 shares of common stock in the form of restricted stock units on 11/18/2025 at a stated price of $0, reflecting that this is a stock-based compensation grant rather than an open-market purchase. These restricted stock units vest in four equal annual installments beginning on November 18, 2026, meaning the executive earns the shares over time if service conditions are met.

After this award, the executive beneficially owns 12,535.056 shares of Agilent common stock directly. This total includes 137.654 shares acquired through an Employee Stock Purchase Plan under Section 423 of the Internal Revenue Code in a transaction exempt under Rule 16b-3. The filing is made on Form 4 by a single reporting person in the capacity of officer.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DiMarco Bret

(Last) (First) (Middle)

5301 STEVENS CREEK BLVD.

(Street)

SANTA CLARA CA 95051

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AGILENT TECHNOLOGIES, INC. [ A ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior Vice President

3. Date of Earliest Transaction (Month/Day/Year)
11/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/18/2025		A		6,922	A	$0(1)	12,535.056(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted Stock Units granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. The restricted stock units vest in four equal annual installments beginning on November 18, 2026.

2. Includes 137.654 shares acquired in an Employee Stock Purchase Plan under Section 423 of the Internal Revenue Code of 1986, as amended, in a transaction exempt under Rule 16b-3.

	/s/ Bret DiMarco	11/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Agilent Technologies (A) disclose in this Form 4 filing?

Agilent Technologies reported that a Senior Vice President received 6,922 restricted stock units of common stock on 11/18/2025 as part of equity compensation.

Who is the reporting person in this Agilent (A) Form 4 and what is their role?

The reporting person is an officer of Agilent Technologies, serving as Senior Vice President, and is required to report changes in their beneficial ownership of company stock.

How do the 6,922 restricted stock units granted by Agilent vest?

The 6,922 restricted stock units vest in four equal annual installments beginning on November 18, 2026 under the Agilent Technologies, Inc. 2018 Stock Plan.

What is the total number of Agilent (A) shares the officer owns after this transaction?

Following the reported grant, the officer beneficially owns 12,535.056 shares of Agilent common stock directly.

Does the Agilent (A) Form 4 include shares from an Employee Stock Purchase Plan?

Yes. The beneficial ownership total includes 137.654 shares acquired under an Employee Stock Purchase Plan under Section 423 of the Internal Revenue Code in a transaction exempt under Rule 16b-3.

Was any cash paid for the 6,922 Agilent restricted stock units reported?

The Form 4 lists a price of $0 for the 6,922 restricted stock units, indicating they were granted as equity compensation rather than bought in the market.